Social Media Ideas for Translational Medicine

Why Multidisciplinary Teams Matter in Translational Transcriptomics

RNA sequencing delivers its greatest clinical value when multidisciplinary teams integrate laboratory, computational, and clinical expertise to ensure findings are accurate, interp...

CCRM Ireland Would Be Established to Hasten Translation of Advanced Therapies Into Patient Treatments

The partnership will explore how to advance the design and clinical translation and delivery of personalized immune cell therapies, while also leveraging Ireland’s biopharmaceutica...

Next Generation Biopharma Innovation

In a quest to provide more relevant translational data, traditional in vivo models join forces with new approach methodologies. The post Next Generation Biopharma Innovation appear...

One Antibody, Fewer Scientific Surprises

Why maintaining translational continuity across preclinical research models can make or break confidence in experimental results. The post One Antibody, Fewer Scientific Surprises...

Advancements in mRNA Technology, Clinical Modalities, and Future Horizons in Science

BioTrinity 2026 Showcases Delivery Technologies and Promising Therapeutic Candidates

All the technologies featured at BioTrinity 2026 have the goal of addressing unmet needs in areas like chronic wounds and ophthalmic diseases, and the associated companies highligh...

From Trial-and-Error to Targeted Success: How Computational Disease Models Can Help Patients and Pharma Companies

The in-depth, constantly-changing birds-eye view of disease that computational models provide is an essential next step in linking our ever-expanding clinical knowledge and data wi...

Thinking Machines: Large Models Transform Medicine

In recent years, artificial intelligence (AI) has demonstrated extraordinary capabilities in uncovering hidden patterns, predicting outcomes, and identifying correlations across va...

Critical Path Institute Unveils New Coalition to Propel Human-Relevant Drug Development Tools

TUCSON, Ariz., and AMSTERDAM — May 19, 2026 — In a transformative step for drug development and regulatory science, the Critical Path Institute (C-Path) has officially launched the...

CAMP4 Therapeutics preprints pioneering study on regulatory RNA profiling and gene upregulation

RNA sequencing with regRNA Capture-seq identified thousands of regulatory RNAs and enabled new strategies to increase expression of disease-related genes using ASOs...

From Discovery to Development in Emerging Modalities

ProBio is building flexible platforms for multispecific antibodies, ADCs, and other advanced therapeutic approaches. The post From Discovery to Development in Emerging Modalities a...

Five-mRNA Cocktail Shows Promise in Reducing Heart Failure Post-Myocardial Infarction

Heart failure following myocardial infarction has long presented a formidable challenge to clinicians worldwide. Despite advances in acute cardiac care, the progression from initia...

Matching life saving transplants inside UHN’s Transplant Immunology Lab

HN Summary • UHN’s Transplant Immunology Lab plays a critical role in matching donor organs and stem cells, ensuring safe and successful transplants.  • Using advanced HLA testing...

Missing infrastructure for real-world predictive AI impact

Health systems are under increasing pressure as chronic disease becomes the dominant burden of care. Addressing this requires earlier detection and prevention, and predictive artif...

Oligonucleotide Therapeutic Industry Readies Itself to Move to the Next Phase

As synthetic oligonucleotide therapeutics become validated and feasible for commercial production, manufacturers are being urged to become familiar with the Chemistry, Manufacturin...

A genome-first multiomic approach to diagnosis

Did you know that one in 10 Americans have a rare disease and it can take five or more years, on average, for a person with a rare disease to get an accurate diagnosis? That’s more...

<![CDATA[Abu Dhabi Advances an Integrated Model for Global Life Sciences Innovation ]]>

<![CDATA[The Future for Disease Modifying Therapies for Lysosomal Disorders]]>

Harrington Discovery Institute Uncovers Novel Drug Targets for Challenging Cancer Types

Despite remarkable progress in medical science, the prognosis for most patients diagnosed with advanced-stage cancers remains bleak. The challenge lies not only in the complexity o...

Bonito Biosciences and DaltonTx Collaborate on Precision Delivery for Oligotherapeutics

By combining closed-loop functional screening with AI-driven design, Bonito and DaltonTx aim to accelerate discovery of delivery systems that can reach tissues and cell types that...

Alithea Genomics launches early access program for MERCURIUSâ„¢ 1536 DRUG-seq, bringing transcriptomics to compound scre...

MERCURIUSâ„¢ 1536 DRUG-seq brings RNA sequencing to large-scale compound screening, enabling efficient gene expression profiling... The post Alithea Genomics launches early access...

Precise Gene Control Using FDA-Approved RNA Splicing Drug

In a groundbreaking advance poised to reshape gene therapy and molecular medicine, researchers have unveiled a novel strategy for precise gene regulation via RNA splicing modulatio...

Immuneel, Tata Memorial Centre partner to advance cell and gene therapy research

Among the first projects identified under the partnership is a Phase 2 extension study evaluating the safety and efficacy of IMN-003A cell therapy in adult and paediatric patients...

Engineering Drug-Responsive RNA for Precise Control

In a groundbreaking advance poised to reshape the landscape of RNA therapeutics, researchers have engineered a novel drug-responsive replication machinery capable of exerting exqui...